Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Open Access
- 18 September 2017
- journal article
- research article
- Published by Elsevier BV in Neurotherapeutics
- Vol. 15 (1), 178-189
- https://doi.org/10.1007/s13311-017-0572-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsAnnals Of Oncology, 2012
- Longitudinal assessment of oxaliplatin-induced neuropathyNeurology, 2011
- Dose Effects of Oxaliplatin on Persistent and Transient Na+ Conductances and the Development of NeurotoxicityPLOS ONE, 2011
- Interventions for preventing neuropathy caused by cisplatin and related compoundsPublished by Wiley ,2011
- Thermoreception and nociception of the skin: a classic paper of Bessou and Perl and analyses of thermal sensitivity during a student laboratory exerciseAdvances in Physiology Education, 2010
- Thermoreceptors and thermosensitive afferentsNeuroscience & Biobehavioral Reviews, 2010
- Tools for Assessing Neuropathic PainPLoS Medicine, 2009
- Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced NeurotoxicityJournal of Clinical Oncology, 2009
- The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity ScaleJournal of the Peripheral Nervous System, 2007
- Quantitative sensory testing: a comprehensive protocol for clinical trialsEuropean journal of pain, 2006